Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AOB - American Oriental Bioengineering Inc. -- Ignore unavailable to you. Want to Upgrade?

To: gladman who wrote (42)	5/12/2006 9:50:29 AM
From: gladman	Respond to of 47

American Oriental 1Q Profit Doubles Friday May 12, 9:24 am ET American Oriental Bioengineering Shares Rise in Premarket Trading As 1st-Quarter Profit More Than Doubled NEW YORK (AP) -- American Oriental Bioengineering Inc., a China-based maker of herbal supplements, on Friday said first-quarter profit more than doubled as revenue soared. Net income jumped to $4.9 million, or 8 cents per share, compared with $2.2 million, or 5 cents per share, during the year-ago period. The number of shares outstanding increased to 61.3 million from 42.7 million. Revenue climbed 98 percent to $19.1 million from $9.7 million last year. The company said sales of its Cease Enuresis Soft Gel and Patch product, along with its Shuanghuanlian Injection Powder, more than doubled during the quarter. In premarket electronic trading, shares rose 31 cents, or 6 percent to $5.45. On Thursday, shares closed at $5.14 on Thursday on the American Stock Exchange

To: gladman who wrote (42)	5/17/2006 7:22:57 AM
From: Alfred W. Post	Respond to of 47

Hi, if further holding on is stupid, then I am stupid. My cost is a bit higher than M&S BUT i SEE MORE POTENTIAL